Nitric oxide modulation of neutrophil-endothelium interaction: Difference between arterial and venous coronary bypass grafts

Journal of the American College of Cardiology

Volumn 31, Issue 4, 1998, Pages 823-826

  Chello, Massimo ^a,c   Mastroroberto, Pasquale ^a   Perticone, Francesco ^a   Celi, Vittoria ^a   Colonna, Alfredo ^b  

^a Cardiac Surgery Unit   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; BINDING AFFINITY; CELL ADHESION; CELL INTERACTION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUTROPHIL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SAPHENOUS VEIN;

ADULT; AGED; CELL ADHESION; CORONARY ARTERY BYPASS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MAMMARY ARTERIES; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; SAPHENOUS VEIN;

EID: 0032521006     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00560-3     Document Type: Article

References (35)

1. 1. Tector AJ, Schmahl TM, Janson B, Kallier JR, Johnson G. The internal mammary artery graft: its longevity after coronary bypass. JAMA 1981;246: 2181-3.
2. 2. Grondin CM, Campenau L, Lesperance J, Enjalbert M, Bourassa MG. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation 1984;70(Pt 2):208-12.
3. 3. Sisto T, Yla-Herttuala S, Luoma J, Riekkinen H, Nikkari T. Biochemical composition of human internal mammary artery and saphenous vein. J Vasc Surg 1990;11:418-22.
4. 4. Ricevuti G, Mazzone A. The neutrophils revisited. Inflammation 1989;13: 475-82.
5. 5. Ross R. The pathogenesis of atherosclerosis. N Engl J Med 1986;314:488-500.
6. 6. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic heart disease. JAMA 1987;257:2318-24.
7. 7. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986;251:H314-9.
8. 8. Engler R, Lucchesi BR. Granulocyte and oxidative injury in myocardial ischemia and reperfusion. Fed Proc 1987;46:2395-402.
9. 9. Weiss SJ, Young J, LoBuglio AF, Slivka A, Mineh NF. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest 1981;68:714-21.
10. 10. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288: 373-6.
11. 11. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-18.
12. 12. Moncada S, Palmer RMJ, Higgs FA. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol 1989;38:1709-15.
13. 13. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327: 524-6.
14. 14. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
15. 15. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992;262:H611-5.
16. 16. Lo SK, Detmers PA, Levin SM, Wright SD. Transient adhesion of neutrophils to endothelium. J Exp Med 1989;169:1779-93.
17. 17. Ma X, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993;72:403-12.
18. 18. Unni KK, Kottke BA, Titus JC, Frye RL, Wallace RB, Broen AL. Pathological changes in aorto-coronary saphenous vein grafts. Am J Cardiol 1974;34:526-32.
19. 19. Fuchs JCA, Mitchener JS, Hager PO. Postoperative changes in autologous vein grafts. Ann Surg 1978;188:1-15.
20. 20. Neitzel GF, Barboriak JJ, Pintar K, Qureshi I. Atherosclerosis in aortocoronary bypass grafts: morphologic study and risk factor analysis 6 to 12 years after surgery. Atherosclerosis 1986;6:594-600.
21. 21. de Gaetano G, Evangelista V, Rajtar G, Del Maschio A, Cerletti C. Activated polymorphonuclear leukocytes stimulate platelet function. Thromb Res 1990;110 Suppl XI:25-32.
22. 22. Philip RB, Webb CD. Failure of platelets to enhance aggregation of temperature-stabilized neutrophils: effects of warming and of drugs. Prostaglandins, Leuko Med 1987;30:93-103.
23. 23. Boogaerts MA, Yamada AO, Jacob HS, Moldow CF. Complement-induced granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc Natl Acad Sci USA 1982;79:7019-23.
24. 24. Angelini GD, Bryan AJ, Williams HMJ, Morgan R, Newby AC. Distension promotes platelet and leukocyte adhesion and reduces short term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg 1990;99:433-9.
25. 25. Boerboom LE, Olinger GN, Tie-Zhu L, Rodriguez ER, Ferrans VJ, Kissebah AH. Histologic, morphometric, and biochemical evolution of vein bypass grafts in nonhuman primate model. J Thorac Cardiovasc Surg 1990;99:97-106.
26. 26. Brody WR, Kosek JC, Angel WW. Changes in vein grafts following aorto-coronary bypass induced by pressure and ischemia. J Thorac Cardiovasc Surg 1972;64:847-54.
27. 27. Kling D, Holzschuch T, Strohschneider T, Betz E. Enhanced endothelial permeability and invasion of leukocytes into the artery wall as initial events in experimental atherosclerosis. Int Angiol 1987;6:21-8.
28. 28. Nash GB, Shearman C. Neutrophils and peripheral arterial disease. Crit Ischaemia 1992;2:5-13.
29. 29. Ricevuti G. Neutrophil aggregation: present and perspective in medical pathology. In: Mauri C, Rizzo SC, Ricevuti G, editors. The Biology of Phagocytes in Health and Disease. Oxford: Pergamon, 1987:521.
30. 30. Moilanen E, Vuorinen P, Kankaareranta H, Metsa-Ketela T, Vapaatalo H. Inhibition by nitric oxide donors of human polymorphonuclear leukocyte functions. Br J Pharmacol 1993;109:852-8.
31. 31. Yang Z, von Segesser L, Bauer E, Stulz P, Turina M, Luscher TF. Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ Res 1991;68:52-60.
32. 32. Yang Z, Stulz P, von Segesser L, Bauer E, Turina M, Luscher TF. Different interactions of platelets with arterial and venous coronary bypass vessels. Lancet 1991;337:939-43.
33. 33. Luscher TF, Diederich D, Siebenmann R, et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 1988;319:462-7.
34. 34. Pearson PJ, Evora PRB, Schaff HV. Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency. Ann Thorac Surg 1992;54:1078-84.
35. 35. Chua YL, Pearson PJ, Evora PRB, Schaff HV. Detection of intraluminal release of endothelium-derived relaxing factor from human saphenous veins. Circulation 1993;88(Pt 2):128-32.